LIST OF FINISHED FORMULATION FOROM JAN-2010 TO MARCH-2011

S.NO. NAME OF I/A NAME OF MFT

SITE
DRUGS NAME VALIDITY
PERIOD
1.
ABBOTT
HEALTHCARE
PVT. LTD.,
PIERRE FABRE
MEDICAMENT
PRODUCTION,
VINORELBINE (NAVELBINE)10 mg/ml (Vials ! 1ml a"# $ml)
CONCENTRATE FOR %OLUTION FOR INFU%ION
01/1&/&010 TO
'0/11/&01'
2.
ABBOTT
HEALTHCARE
PVT. LTD.,
(ILEAD %CIENCE% INC., LIPO%OMAL AMPHOTERICIN B FOR IN)ECTION $0M(
AMPHOTERICIN B ENCAP%ULATED IN LIPO%OME%
*L+OPHILLI%ED PO,DER FOR INTRAVENOU% INFU%ION
(AMBIO%OME)
01/1&/&010 TO
'0/11/&01'
3.
ABBOTT
HEALTHCARE
PVT. LTD.,
AMO UPP%ALA AB, %ODIUM H+ALURONATE %OLUTION F- I".-a * O/0la- L1"s1s2*
%ODIUM H+ALURONATE 10mg/ml (HEALON) %ODIUM
H+ALURONATE &'mg/ml (HEALON $)
01/1&/&010 TO
'0/11/&01'
4.
L( LIFE %CIENCE%
INDIA PVT. LTD.
DON( 3OO3 PARMA
CO. LTD. 455*$,
)U3H+UN *RI,
3,AN(H+E,ON*
M+UN )INCHENON*
(UN,
CHOON(CHEON(BOO3
*DO,
LEUPROLIDE ACETATE DEPOT IN)ECTION (EACH VIAL
CONTAIN%2LEUPROLIDE '.6$ M()
01/04/&011 TO
'1/0'/&014
5.
DR.REDD+%
LABORATORIE%
LIMITED
LABORATORIE%
THI%EN %.A. &7, RUE DE
LA PAP+REE 14&0,
BRAINE*L ALLEUD,
O8ALIPLATIN $0M( AND 100M( PO,DER FOR %OLUTION
FOR INFU%ION
01/10/&010 TO
'0/09/&01'
6.
ALCON
LABORATORIE%
(INDIA)PVT.LTD.
ALCON LABORATORE%,
INC, 7&01, %OUTH
FREE,A+, FORT
,ORTH TE8A%
1.FDC OF H+DRO8+ PROP+L METH+L CELLULO%E (HPMC):
DE8TRAN 60:(L+CERIN LUBRICANT E+E DROP
COMPO%ITION2 H+DRO8+ PROP+L METH+L CELLULO%E
U%P;..0.'< ,/V DE8TRAN 60;..0.1<,/V (L+CERIN ;;
0.1<,/V &.PREDNI%OLONE ACETATE OPTHALMIC
%U%PEN%ION U%P 1< '.OLOPATADINE H+DROCHLORIDE
OPTHALMIC %OLUTION (0.&<) EACH ML CONTAIN%2
OLOPATADINE H+DROCHLORIDE E=UIVALENT TO
OLOPATADINE;;..&M( 4.MO8IFLO8ACIN OPTHALMIC
%OLUTION (0.$<) EACH ML OF OPTHALMIC %OLUTION
CONTAIN% ;;;MO8IFLO8ACIN H+DROCHLORIDE
E=UIVALENT TO MO8IFLO8ACIN BA%E ;;$ M(
$.BALANCED %ALT INTRAOCULAR IRRI(ATIN( %OLUTION
ENRICHED ,ITH DE8TRO%E AND (LUTATHIONE ) %TERILE2
PART I 2EACH ML CONTAIN%2%ODIUM CHLORIDE ;.7.4 M(
POTA%%IUM CHLORIDE ;;.0.'9$ M( DIBA%IC %ODIUM
PHO%PHATE (ANH+DROU%);..0.4''M( %ODIUM
01/0'/&011 TO
&5/0&/&014
BICARBONATE ;.&.19M( H+DROCHLORIC ACID AND/OR
%ODIUM H+DRO8IDE .....(TO AD)U%T PH) ,ATER FOR
IN)ECTION.....=.% PART II 2EACH ML CONTAIN%2 CALCIUM
CHLORIDE DIH+DRATE ....'.5$ M( MA(NE%IUM CHLORIDE
HE8AH+DRATE ....$.00M(
DE8TRO%E(ANH+DROU%)......&'.00M( (LUTATHIONE
DI%ULFIDE (O8IDI%ED (LUTATHIONE ) ......4.70M(
,ATER FOR IN)ECTION.....=.% 7.NEPAFENAC OPTHALMIC
%U%PEN%ION EACH ML CONTAIN%2NEPAFENAC ;;;.1M(
7.
%EPTODONT
HEALTHCARE
INDIA PVT. LTD.
%EPTODONT $5, RUE DU
PONT DE CRETEIL
94100 %AINT*MAUR DE%
FO%%E% CEDE8
1.CAU%TINERF ,ITHOUT AR%ENIC (PA%TE FOR DENTAL
U%E INTENDED FOR THE DEVITALI%ATION OF THE DENTAL
PULP) &.CRE%OPHENE (%OLUTION FOR DENTAL U%E
INTENDED FOR THE DI%INFECTION OF ROOT CANAL% IN
THE DENTAL PRACTICE%) '.LI(NO%PAN %PECIAL
(IN)ECTABLE %OLUTION FOR DENTAL U%E INTENDED FOR
LOCAL OR LOCO*RE(IONAL ANE%THE%IA IN DENTAL
%UR(ER+) 4.ENDOMETHA%ONE N (PO,DER FOR DENTAL
U%E INTENDED FOR ROOT CANAL FILLIN( AND %EALIN(
IN DENTAL PROCEDURE%) $.%EPTANE%T ,ITH ADNELAINE
1/100,000 7.%CANDONE%T '<PLAIN (IN)ECTABLE %OLUTION
FOR DENTAL U%E FOR DENTAL U%E INTENDED FOR LOCAL
OR LOCO*RE(IONAL ANE%THE%IA IN DENTAL %UR(ER+)
6.8+LONOR %PRA+ (FOR DENTAL U%E INTENDED FOR
TOPICAL ANE%THE%IA)
01/05/&010 TO
'1/06/&01'
8.
B.BRAUN
MEDICAL (INDIA)
PVT LTD
B.BRAUN MEL%UN(EN
A(, PRODUCTION
PLANT >P> , AM
%CH,ER?EL%HOF 1,
'4&1& MEL%UN(EN,
1. $< (LUCO%E $00ML,1000ML IP &. 0.9< NaCl 100ML, &$0ML,
$00ML, 1000ML IP '. 0.9< NaCl AND $< (LUCO%E
$00ML,1000ML IP 4. 10< (LUCO%E $00ML,1000ML IP $.
COMPOUND %ODIUM LACTATE $00ML,1000ML FDC OF
%ODIUM CHLORIDE :POTA%%IUM CHLORIDE :CALCIUM
CHLORIDE DIH+DRATE :MA(NE%IUM CHLORIDE
HE8AH+DRATE: %ODIUM ACETATE TRIH+DRATE: L*
MALIC ACID %OLUTION FOR %TERILE %OLUTION FOR
INFU%ION EACH 1000 ML %OLUTION CONTAIN% %ODIUM
CHLORIDE ...7.50(M POTA%%IUM CHLORIDE...0.'0(M
CALCIUM CHLORIDE DIH+DRATE...0.'6(M MA(NE%IUM
CHLORIDE HE8AH+DRATE....0.&0(M %ODIUM ACETATE
TRIH+DRATE....'.&6(M L*MALIC ACID.....0.76(M
01/07/&011 TO
'1/0$/&014
9.
(LA8O%MITH3LI
NE
PHARMACEUTICA
L% LIMITED
(LA8O ,ELLCOME
PRODUCTION, 1 RUE DE
I@ ABBA+E*67970,
NOTRE DAME DE
BONDEVILLE,
1. NADROPARIN CALCIUM IN)ECTION 2 FRA8IPARINE
IN)ECTION(PREFILLED %+RIN(E%*0.&ML, 0.'ML, 0.4ML,
0.7ML, 0.5ML, 1.0MLA9$00 ANDTI*8A IU/ML , FRA8IPARINE
IN)ECTION (MULTIDO%E VIAL%*$ML, 1$ML, A9$00 ANTI*8A
IU/ML), FRA8ODI IN)ECTION(PREFILLED %+RIN(E%*0.7ML,
0.5ML 1.0MLA19000 ANTI*8A IU/ML) &. FONDAPARINU8
%ODIUM IN)ECTION2* (PREFILLED %+RIN(E%*&.$M(/0.$ML),
01/01/&011 TO
'1/1&/&01'
(PREFILLED %+RIN(E% 0.4ML, 0.7ML B 0.5ML*1&.$M(/ML)
10.
M%D
PHARMACEUTICA
L% PVT. LTD.
MERC3 %HARP AND
DOHME B.V.,
,AARDER,E( '9, &0'1
BN HAARLEM,
RI?ATRIPTAN BEN?OATE ORALL+ DI%INTE(RATIN(
TABLET% EACH ORAL DI%INTE(RATIN( TABLET
CONTAIN%2 RI?ATRIPTAN BEN?OATE E=UIVALENT TO
RI?ATRIPTAN;;;;10M(
'0/07/&009 TO
'0/07/&01&
11.
UR%APHARM
INDIA PRIVATE
LTD.
UR%APHARM,
AR?NEIMITTEL (MBH,
INU%TRIE%TRABE '$,
771&9 %AARBRUC3EN,
1. POVIDONE &0 M(/ML &. 8+LOMETA?OLINE
H+DROCHLORIDE
01/07/&011 TO
'1/0$/&01'
12.
?AMBON (INDIA)
PVT. LTD.
?AMBON
%,IT?ERLAND
LTD.VIA INDU%TRIA,
1'*CH*7514,
CADEMPINO
FO%FOM+CIN TROMETAMOL %ACHET% EACH %ACHET
CONTAIN%2 FO%FOM+CIN TROMETAMOL ;.$.7'1 (M
E=UIVALENT TO FO%FOM+CIN;..'(M
01/0'/&010 TO
&5/0&/&014
13.
%OLVA+ PHARMA
INDIA LIMITED
%OLVA+
PHARMACEUTICAL%
,R0.1 D1
BELLEVILLE,LIEU*DIT
MAILLARD,01400
CHATILLON %UR
CHALARONNE,FRANCE
MO8ONIDINE TABLET% 2* EACH FILM COATED TABLET
CONTAIN%2* MO8ONIDINE;.0.&M(/0.'M(/0.4M(
01/0'/&011 TO
&5/0&/&014
14.
NOVARTI% INDIA
LTD.
E8CELVI%ION, RUE DE
LA LOMBARDIERE,
06100 ANNONA+,
H+DRO8+PROP+L METH+LCELLULO%E OPTHALMIC
%OLUTION U%P
01/06/&011 TO
'0/07/&014
15.
PFI?ER
PRODUCT% INDIA
PVT. LTD.,
PFI?ER
MANUFACTURIN(
BEL(IUM NV
RI)3%,E( 1&,&560
PUUR%,
1. FRA(MIN %OLUTION FOR IN)ECTION 10,000 IU/ml,10ml
VIAL 1. FRA(MIN %OLUTION FOR IN)ECTION &$00 IU/ml, 4ml
AMPOULE &. FRA(MIN %OLUTION FOR IN)ECTION &$00
IU/ml, 4ml VIAL '. FRA(MIN %OLUTION FOR IN)ECTION &.
%OLU*MEDROL 40M( 1ML ACT*O*VIAL 1. %OLU*MEDROL
1&$M( &ML ACT*O*VIAL . %OLU*MEDROL $00M( 5ML VIAL
%TERILE PO,DER . %OLU*MEDROL 1000M(, 17ML VIAL
%TERILE PO,DER '. DEPO*MEDROL %TERILE A=UEOU%
%U%PEN%ION 40M(/ML, 1ML VIAL DEPO*MEDROL %TERILE
A=UEOU% %U%PEN%ION 40M(/ML, &ML VIAL 4. DALACIN C
%TERILE %OLUTION 1$0M(/ML, &ML AMPOULE .DALACIN C
%TERILE %OLUTION 1$0M(/ML, 4ML AMPOULE $. DEPO*
PROVERA %TERILE A=UEOU% %U%PEN%ION 1$0M(/ML, 1ML
VIAL DEPO*PROVERA %TERILE A=UEOU% %U%PEN%ION
1$0M(/ML, 1ML DI%PO%ABLE %+RIN(E 7. 8ALATAN E+E
DROP% $0MC(/ML 6. HEMABATE IN)ECTION &$0MC(/ML5.
PREPIDIL (EL 0.$M( 9. 8ALACOM E+E DROP% 10.
LUTAL+%E $M(/ML %TERILE %OLUTION (VETERINAR+
PRODUCT) 11. C+CLO3APRON IN)ECTION 100M(/ML
01/0'/&011 TO
&5/0&/&014
16.
BRI%TOL*M+ER% BRI%TOL M+ER% 1. PACLITA8EL N)ECTION*'0M(,100M(,'00M( VIAL &. 01/0'/&011 TO
%=UIBB INDIA
PVT. LTD.,
%=UIBB
COMPAN+,NE,+OR3
U%A HAVIN( TOLL
MANUFACTURIN( %ITE
ATCORDEN PHARMA
LATINA %.P.A, VIA DEL
MURILLO, 3M
&.500,0401',
%ERMONETA, LATINA,
CEFEPIME IN)ECTION*EACH VIAL CONTAIN%2 CEFIPIME (A%
HCL);.1(M/&(M VIAL '. CARBOPLATIN A=UEOU%
%OLUTION IN)ECTION*1$0M(/1$ML,B4$0M(/4$ML
&5/0&/&014
17.
RANBA8+
LABORATORIE%
LTD.
ON+, INC. 1$67 %,EET
HOME ROAD
AMHER%T, NE, +OR3,
%U%PEN%ION FOR INTRATRACHEAL IN%TILLATION2* E ACH
ML OF %U%PEN%ION CONTAIN%2* TOTAL
PHO%PHOLIPID%;.'$M((CONTAININ( &7 M(
PHO%PHATID+LCHOLINE OF ,HICH 17M( I%
DI%ATURATED PHO%PHATID+LCHOLINE) PROTEIN%;0.7$
M((INCLUDIN( 0.&7M( OF %URFACTANT A%%OCIATED
PROTEIN% B)
01/0'/&011 TO
&5/0&/&014